11.07.2015 Views

Pathology of the Head and Neck

Pathology of the Head and Neck

Pathology of the Head and Neck

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Lesions <strong>of</strong> Squamous Epi<strong>the</strong>lium Chapter 1 13up <strong>and</strong> avoidance <strong>of</strong> exposure to known risk factors isimportant due to <strong>the</strong> risk <strong>of</strong> malignant transformation[47, 263, 334]. Recurrences <strong>of</strong> high-risk SILs are not infrequentevents, being reported in 18% <strong>of</strong> lesions thathad been excised with free surgical margins [366]. If <strong>the</strong>size or o<strong>the</strong>r clinical obstacles make surgical treatment<strong>of</strong> oral SILs difficult, various antioxidants, such as betacarotene<strong>and</strong> <strong>the</strong> retinoids, are most commonly used forchemoprevention [191].The occurrence <strong>of</strong> <strong>the</strong> higher grades (moderate <strong>and</strong>severe dysplasia, atypical hyperplasia) <strong>of</strong> oral SILs isconsidered <strong>the</strong> most important risk <strong>of</strong> SCC development.The reported frequency <strong>of</strong> malignant transformation<strong>of</strong> OL ranges from 3.1% [373] to 17.5% [323]. Severallocations <strong>of</strong> OL, toge<strong>the</strong>r with histological abnormalities,are linked with higher malignant transformation.The floor <strong>of</strong> <strong>the</strong> mouth is, thus, <strong>the</strong> highest risk site, followedby <strong>the</strong> tongue <strong>and</strong> lip [319].The clinical appearance <strong>of</strong> non-homogenous or speckledOL may correlate with <strong>the</strong> likelihood that <strong>the</strong> lesionwill show epi<strong>the</strong>lial changes or malignant transformation.In a study by Silverman <strong>and</strong> Gorsky <strong>the</strong> overall malignanttransformation <strong>of</strong> OL was 17.5%, for <strong>the</strong> homogenousform only 6.6%, <strong>and</strong> for speckled OL 23.4%. Aspecial subtype <strong>of</strong> OL, PVL, was found to develop SCCin 70.3% <strong>of</strong> patients [322]. Compared with OL, OE hassignificantly worse biological behaviour, with 51% proceedingto malignant transformation [319].1.2.7.2 LarynxThe main task <strong>of</strong> <strong>the</strong> pathologist dealing with laryngealSILs is to separate non-risky or a minimally riskyfrom risky changes. Patients with benign hyperplasticlesions (simple <strong>and</strong> basal-parabasal hyperplasia) donot require such a close follow-up after excisional biopsiesas those with atypical hyperplasia <strong>and</strong> CIS, althoughelimination <strong>of</strong> known detrimental influencesis advised [125, 150]. Diagnosis <strong>of</strong> atypical hyperplasiain laryngeal lesions requires close follow-up <strong>and</strong> <strong>of</strong>tenrepeated histological assessment to detect any possiblepersistence or progression <strong>of</strong> <strong>the</strong> disease [125, 150, 178,181]. Patients with CIS may require more extensive surgicaltreatment or radio<strong>the</strong>rapy, although this is controversial[79, 181, 254, 299, 336].The histopathologic degree <strong>of</strong> severity <strong>of</strong> laryngealSILs is still used as <strong>the</strong> most reliable predictive factor[39, 125, 150, 178, 181, 239]. The frequency <strong>of</strong> subsequentmalignant alteration markedly increases fromsquamous (simple) <strong>and</strong> basal-parabasal (abnormal) hyperplasia(0.9%), compared with atypical hyperplasia(11 %) [150]. Barnes’s review <strong>of</strong> <strong>the</strong> literature shows that<strong>the</strong> risk <strong>of</strong> SCCs developing in mild, moderate <strong>and</strong> severelaryngeal dysplasia ranges from 5.5% to 22.5% <strong>and</strong>28.4% respectively [20].1.3 Invasive Squamous Cell Carcinoma1.3.1 Microinvasive SquamousCell CarcinomaICD-O:8076/3Microinvasive squamous cell carcinoma (SCC) is a SCCwith invasion beyond <strong>the</strong> epi<strong>the</strong>lial basement membrane,extending into <strong>the</strong> superficial stroma. There is little consensusamong pathologists on <strong>the</strong> maximum depth <strong>of</strong>invasion in microinvasive SCCs, but it generally rangesfrom 0.5 mm [20] to 2 mm [77]. The depth <strong>of</strong> invasionmust be measured from <strong>the</strong> basement membrane <strong>of</strong> <strong>the</strong>adjacent (non-neoplastic) surface epi<strong>the</strong>lium, because <strong>of</strong><strong>the</strong> great variations in epi<strong>the</strong>lial thickness.Microinvasive SCC is a biologically malignant lesioncapable <strong>of</strong> gaining access to lymphatic <strong>and</strong> blood vessels,which may result in metastases. However, metastasesare rare in microinvasive SCCs <strong>and</strong> <strong>the</strong> prognosisis excellent. Studies on SCCs <strong>of</strong> <strong>the</strong> floor <strong>of</strong> <strong>the</strong> mouthhave shown that <strong>the</strong>re is little or even no metastatic potentialfor SCCs penetrating less than 2 mm beyond <strong>the</strong>basement membrane, <strong>and</strong> a substantially higher risk <strong>of</strong>metastases in more deeply invasive SCCs at this site [74,77, 246]. The prognosis is also excellent in microinvasiveSCCs <strong>of</strong> <strong>the</strong> laryngeal glottis because <strong>of</strong> <strong>the</strong> poor lymphatic<strong>and</strong> vascular network in this location. Some authorshave <strong>the</strong>refore recommended more conservativetreatment <strong>of</strong> <strong>the</strong>se lesions, such as endoscopic removal,with a careful follow-up [80, 308, 341].The reliable diagnosis <strong>of</strong> microinvasive SCC can onlybe made with certainty if <strong>the</strong> whole lesion is examined.It should not be made in small, tangentially cut biopsyspecimens.1.3.2 Conventional SquamousCell CarcinomaICD-O:8070/3Squamous cell carcinoma (SCC) is a malignant epi<strong>the</strong>lialtumour with evidence <strong>of</strong> squamous differentiationsuch as intercellular bridges <strong>and</strong> keratin formation. Itoriginates from <strong>the</strong> surface squamous epi<strong>the</strong>lium, orfrom ciliated respiratory epi<strong>the</strong>lium that has undergonesquamous metaplasia [242].Squamous cell carcinoma <strong>of</strong> <strong>the</strong> head <strong>and</strong> neck is <strong>the</strong>sixth most prevalent cancer worldwide, accounting for5% <strong>of</strong> all new cancers, with a global annual incidence<strong>of</strong> 500,000 [42]. The vast majority <strong>of</strong> SCCs are <strong>the</strong> conventionaltype <strong>of</strong> SCC, accounting for more than 90%<strong>of</strong> cases. The remaining cases belong to <strong>the</strong> variants <strong>of</strong>SCC, which will be discussed later in this chapter.Squamous cell carcinoma <strong>of</strong> <strong>the</strong> head <strong>and</strong> neck occursmost frequently in <strong>the</strong> oral cavity <strong>and</strong> lip, in <strong>the</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!